The use of tranexamic acid in spine surgery.

Patients undergoing surgical procedures of the spine with associated large volume blood loss often require perioperative blood conservation strategies. Synthetic antifibrinolytic medications such as tranexamic acid (TXA) may reduce blood transfusion requirements and postoperative complications following spinal procedures. Studies investigating the role of TXA in spine surgery have presented promising results and have proven its safety and efficacy. However, further investigation is needed to determine the optimal dosing regimen of TXA. In this article, we provide an overview of the basic science and pharmacology of TXA. A comprehensive summary of the findings from clinical trials and a review of the literature that demonstrate the risks and benefits of TXA in spine surgery are also presented.

[1]  R. Prakash,et al.  COMPARATIVE EVALUATION OF EFFECT OF ORAL CLONIDINE AND ORAL GABAPENTIN PREMEDICATION ON INTRAOPERATIVE HAEMODYNAMIC CHANGES IN LAPAROSCOPIC CHOLECYSTECTOMY- A PROSPECTIVE, RANDOMIZED, DOUBLE- BLIND, PLACEBOCONTROLLED STUDY , 2018 .

[2]  Alan H. Daniels,et al.  Development of a preoperative predictive model for major complications following adult spinal deformity surgery. , 2017, Journal of neurosurgery. Spine.

[3]  T. Chinachoti,et al.  Two Doses of Tranexamic Acid Reduce Blood Transfusion in Complex Spine Surgery: A Prospective Randomized Study , 2015, Spine.

[4]  F. Schwab,et al.  Antifibrinolytics Reduce Blood Loss in Adult Spinal Deformity Surgery: A Prospective, Randomized Controlled Trial , 2015, Spine.

[5]  Rachel N. Rattenni,et al.  Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta-analysis. , 2015, The spine journal : official journal of the North American Spine Society.

[6]  I. Roberts,et al.  Tranexamic acid for surgical bleeding , 2014, BMJ : British Medical Journal.

[7]  T. Errico,et al.  The relative efficacy of antifibrinolytics in adolescent idiopathic scoliosis: a prospective randomized trial. , 2014, The Journal of bone and joint surgery. American volume.

[8]  Hailong Zhang,et al.  Efficacy and Safety of Using Antifibrinolytic Agents in Spine Surgery: a Meta-Analysis , 2013, PloS one.

[9]  I. Roberts,et al.  Systematic review, meta‐analysis and meta‐regression of the effect of tranexamic acid on surgical blood loss , 2013, The British journal of surgery.

[10]  O. Boachie-Adjei,et al.  Revision Surgery After Three-Column Osteotomy (3CO) in 335 Adult Spinal Deformity (ASD) Patients: Intercenter Variability and Risk Factors , 2013 .

[11]  Zhi-jun Li,et al.  Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trials , 2013, European Spine Journal.

[12]  S. Ozawa,et al.  Economic considerations on transfusion medicine and patient blood management. , 2013, Best practice & research. Clinical anaesthesiology.

[13]  A. Crawford,et al.  The effect of tranexamic acid in blood loss and transfusion volume in adolescent idiopathic scoliosis surgery: a single-surgeon experience , 2013, Journal of children's orthopaedics.

[14]  Haopeng Li,et al.  Systematic Review and Meta-Analysis of Perioperative Intravenous Tranexamic Acid Use in Spinal Surgery , 2013, PloS one.

[15]  L. Glance,et al.  Blood transfusion in the perioperative period. , 2012, Best practice & research. Clinical anaesthesiology.

[16]  L. Lenke,et al.  Antifibrinolytic Agents Reduce Blood Loss During Pediatric Vertebral Column Resection Procedures , 2012, Spine.

[17]  M. Yagi,et al.  Does the Intraoperative Tranexamic Acid Decrease Operative Blood Loss During Posterior Spinal Fusion for Treatment of Adolescent Idiopathic Scoliosis , 2012 .

[18]  Phil Edwards,et al.  Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis , 2012, BMJ : British Medical Journal.

[19]  M. Farrokhi,et al.  Efficacy of Prophylactic Low Dose of Tranexamic Acid in Spinal Fixation Surgery: A Randomized Clinical Trial , 2011, Journal of neurosurgical anesthesiology.

[20]  K. Ker,et al.  Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. , 2011, The Cochrane database of systematic reviews.

[21]  J. Dettori,et al.  Blood Loss in Major Spine Surgery: Are There Effective Measures to Decrease Massive Hemorrhage in Major Spine Fusion Surgery? , 2010, Spine.

[22]  J. Murkin,et al.  High-Dose Tranexamic Acid Is Associated with Nonischemic Clinical Seizures in Cardiac Surgical Patients , 2010, Anesthesia and analgesia.

[23]  I. Nilsson,et al.  Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid. , 2009, Scandinavian journal of haematology.

[24]  B. Granstrand,et al.  Biochemistry and toxicology of amikapron; the antifibrinolytically active isomer of AMCHA. (A comparative study with epsilon-aminocaproic acid). , 2009, Acta pharmacologica et toxicologica.

[25]  A. Schouten,et al.  The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: A meta-analysis , 2009, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[26]  S. Elwatidy,et al.  Efficacy and Safety of Prophylactic Large Dose of Tranexamic Acid in Spine Surgery: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study , 2008, Spine.

[27]  Du Feng,et al.  The use of antifibrinolytic agents in spine surgery. A meta-analysis. , 2008, The Journal of bone and joint surgery. American volume.

[28]  Y. R. Rampersaud,et al.  Tranexamic Acid Reduces Perioperative Blood Loss in Adult Patients Having Spinal Fusion Surgery , 2008, Anesthesia and analgesia.

[29]  P. Marik,et al.  Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature* , 2008, Critical care medicine.

[30]  Daniel R. Brown,et al.  Antifibrinolytic therapy use to mitigate blood loss during staged complex major spine surgery: Postoperative visual color changes after tranexamic acid administration. , 2006, Anesthesiology.

[31]  C. Samama,et al.  Do Antifibrinolytics Reduce Allogeneic Blood Transfusion in Orthopedic Surgery? , 2006, Anesthesiology.

[32]  A. Vuylsteke,et al.  The impact of administration of tranexamic acid in reducing the use of red blood cells and other blood products in cardiac surgery , 2006, BMC anesthesiology.

[33]  Y. R. Rampersaud,et al.  Intraoperative Adverse Events and Related Postoperative Complications in Spine Surgery: Implications for Enhancing Patient Safety Founded on Evidence-Based Protocols , 2006, Spine.

[34]  D. Bednar,et al.  Tranexamic Acid for Hemostasis in the Surgical Treatment of Metastatic Tumors of the Spine , 2006, Spine.

[35]  D. Neilipovitz.  Tranexamic acid for major spinal surgery , 2004, European Spine Journal.

[36]  S. Colleen,et al.  ROLE OF UROKINASE AND TISSUE ACTIVATOR IN SUSTAINING BLEEDING AND THE MANAGEMENT THEREOF WITH EACA AND AMCA , 1968, Annals of the New York Academy of Sciences.

[37]  S. Arabia,et al.  Tranexamic Acid A Review of its Use in the Treatment of Hyperfibrinolysis , 2012 .

[38]  A. Laupacis,et al.  Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. , 2007, The Cochrane database of systematic reviews.

[39]  Y. Nakajima,et al.  A Prospective, Randomized Study , 2006 .

[40]  H. Kaya,et al.  Tranexamic-acid-induced acute renal cortical necrosis in a patient with haemophilia A. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.